Protect Pharmaceutical Corporation
PRTT
$1.24
-$0.06-4.62%
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 700.00 | 100.00K | 115.40K | 134.40K | 142.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 700.00 | 100.00K | 115.40K | 134.40K | 142.90K |
| Operating Income | -700.00 | -100.00K | -115.40K | -134.40K | -142.90K |
| Income Before Tax | -15.00K | -110.90K | -122.60K | -137.70K | -143.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.02 | -0.11 | -0.12 | -0.14 | -0.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.00K | -110.90K | -122.60K | -137.70K | -143.20K |
| EBIT | -700.00 | -100.00K | -115.40K | -134.40K | -142.90K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | -0.10 | -0.11 | -0.12 | -0.13 |
| Normalized Basic EPS | -0.01 | -0.06 | -0.07 | -0.08 | -0.08 |
| EPS Diluted | -0.01 | -0.10 | -0.11 | -0.13 | -0.13 |
| Normalized Diluted EPS | -0.01 | -0.06 | -0.07 | -0.08 | -0.08 |
| Average Basic Shares Outstanding | 4.45M | 4.45M | 4.45M | 4.45M | 4.45M |
| Average Diluted Shares Outstanding | 4.82M | 4.82M | 4.57M | 4.57M | 4.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
